Table 2 Characteristics of the 33 patients treated with NSAIDs
Baseline | Final | P* | |
|---|---|---|---|
BCVA, logMAR (range) | 0.5 (0.2–1.30) | 0.3 (0.0–1.30) | 0.004 |
CRT, μm (range) | 435 (272–786) | 316 (227–871) | 0.003 |
CCT, μm (range) | 253 (79–358) | 256 (76–382) | 0.175 |
Resolution of PME, n (%) | 19/33 (57.6%) | ||
Duration of treatment, months (range) | 2 (2–9) |